8.9 C
Beijing
Saturday, February 14, 2026

L’Oréal’s Q4 Sales Growth Slows, Missing Expectations Amidst Asian Weakness

L'Oréal's fourth-quarter sales growth of 6% missed expectations, impacted by its luxury division and weakness in Asia, despite strong performance in North America and Europe.

Zhipu AI’s GLM-5 Arrives: A New Challenger in the Global AI Arena

Zhipu AI launches its new flagship model, GLM-5, featuring advanced coding and agentic capabilities, challenging global AI leaders and emphasizing China's growing role in AI development.

Safran Soars: Aerospace Giant Boosts 2028 Targets on Strong Aftermarket and Defense Performance

French aerospace firm Safran raises its 2028 financial outlook significantly, driven by strong civil engine aftermarket demand and robust defense sector performance in its latest fiscal year.

Doximity Shares Surge 36% Following Strong Quarterly Earnings

BusinessDoximity Shares Surge 36% Following Strong Quarterly Earnings

Doximity shares experienced a significant surge of 36% following the release of its fiscal third-quarter earnings, which outperformed Wall Street’s expectations. The digital platform for medical professionals reported a 25% increase in revenue, reaching $168.6 million, compared to $135.3 million in the same period last year.

For the upcoming fiscal fourth quarter, the company projects revenue between $132.5 million and $133.5 million, surpassing analysts’ expectations of $123.8 million. Doximity also raised its full fiscal year guidance, now expecting revenue to land between $564.6 million and $565.6 million.

The company’s adjusted EBITDA saw a remarkable 39% year-over-year increase, reaching $102 million. Analysts at Morgan Stanley responded by raising their price target on the stock from $53 to $71, citing Doximity’s accelerating growth, strong margin performance, and impressive incremental margins. They described this earnings report as a “statement quarter,” highlighting the company’s ability to achieve growth at more than twice the market rate.

Bank of America analysts also noted the strength of Doximity’s performance, attributing its success to favorable comparisons with previous periods, the launch of its client portal, new product expansions, and election-related spending. While they anticipate a more moderate revenue growth rate in fiscal 2026, they believe the company remains well-positioned for long-term expansion, exceeding the growth of the digital advertising market. They raised their price target from $63 to $75 while maintaining a neutral rating on the stock.

Meanwhile, analysts at Leerink Partners upgraded Doximity’s stock from market perform to outperform, increasing their price target from $60 to $90. They pointed to continued core growth trends, the company’s expanding AI investments, and the impact of new product offerings as key drivers of its strong performance. They acknowledged previous skepticism but noted the ongoing growth indicators were too compelling to ignore.

Doximity’s success in capturing market share is largely attributed to its innovative approach to digital healthcare solutions. With telehealth capabilities, referral networks, and up-to-date medical news integrated into its platform, the company continues to attract professionals seeking efficient healthcare technology solutions. The combination of expanding product offerings and increased client engagement positions Doximity for sustained success in the evolving digital health market.

READ MORE:

Check out our other content

Check out other tags:

Most Popular Articles